GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Cyclically Adjusted FCF per Share

Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Cyclically Adjusted FCF per Share : ¥0.14 (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zhejiang Hisoar Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Sep. 2024 was ¥-0.046. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.14 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 91.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Zhejiang Hisoar Pharmaceutical Co was 91.30% per year. The lowest was 22.40% per year. And the median was 45.00% per year.

As of today (2025-03-04), Zhejiang Hisoar Pharmaceutical Co's current stock price is ¥4.64. Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was ¥0.14. Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 33.14.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Hisoar Pharmaceutical Co was 898.00. The lowest was 31.21. And the median was 77.89.


Zhejiang Hisoar Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.02 0.04 0.10 0.14

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.14 0.15 0.15 0.14

Competitive Comparison of Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Zhejiang Hisoar Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Hisoar Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.046/115.7848*115.7848
=-0.046

Current CPI (Sep. 2024) = 115.7848.

Zhejiang Hisoar Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -0.051 99.000 -0.060
201503 0.022 99.900 0.025
201506 0.000 99.500 0.000
201509 0.021 100.500 0.024
201512 0.083 100.600 0.096
201603 0.078 102.200 0.088
201606 0.067 101.400 0.077
201609 0.059 102.400 0.067
201612 0.114 102.600 0.129
201703 0.040 103.200 0.045
201706 0.034 103.100 0.038
201709 0.093 104.100 0.103
201712 -0.159 104.500 -0.176
201803 0.080 105.300 0.088
201806 -0.033 104.900 -0.036
201809 0.171 106.600 0.186
201812 0.131 106.500 0.142
201903 0.048 107.700 0.052
201906 0.092 107.700 0.099
201909 0.063 109.800 0.066
201912 0.077 111.200 0.080
202003 0.099 112.300 0.102
202006 0.073 110.400 0.077
202009 0.096 111.700 0.100
202012 0.012 111.500 0.012
202103 0.010 112.662 0.010
202106 0.002 111.769 0.002
202109 0.040 112.215 0.041
202112 -0.119 113.108 -0.122
202203 0.020 114.335 0.020
202206 -0.038 114.558 -0.038
202209 -0.028 115.339 -0.028
202212 0.001 115.116 0.001
202303 0.060 115.116 0.060
202306 -0.066 114.558 -0.067
202309 0.043 115.339 0.043
202312 -0.005 114.781 -0.005
202403 0.003 115.227 0.003
202406 0.048 114.781 0.048
202409 -0.046 115.785 -0.046

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Zhejiang Hisoar Pharmaceutical Co  (SZSE:002099) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.64/0.14
=33.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Hisoar Pharmaceutical Co was 898.00. The lowest was 31.21. And the median was 77.89.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zhejiang Hisoar Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Hisoar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000
Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.
Executives
Wang Yang Chao Director
Yang Si Wei Directors, executives
Xu Guo Rui Executives
Xu Hua Qing Secretary Dong
Hong Ming Director
Guo Min Long Director
Li Hong Ming Executives
Jiang Ru Dong Securities Affairs Representative
Mao Wen Hua Executives
Sun Yang Director
Li Wei Jin Director
Luo Yu Hong Director
Pan Qing Hua Directors, executives
Chen Zheng Hua Supervisors
Jia Qiang Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines